American Pharmacists Association

LaVoieHealthScience Bolsters Commercial Strategic Communications Expertise with the Hiring of Deborah Plumstead as Vice President

Retrieved on: 
Tuesday, August 16, 2022
Other Communications, Public Relations, Investor Relations, Marketing, Communications, Other Health, Biotechnology, General Health, Health, Science, Other Science, Public relations, Journal of the American Pharmacists Association, Industry, CEO, United Arab Emirates, Kennedy Krieger Institute, Growth, Health communication, American Nurses Foundation, Marketing, Infection, Biotechnology, Neuroscience, American Pharmacists Association, Science, Rheumatology, Ophthalmology, LHS, Health, Medicine

LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of Deborah Plumstead as Vice President of Health Communications.

Key Points: 
  • LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of Deborah Plumstead as Vice President of Health Communications.
  • Ms. Plumstead brings expertise in commercial strategic communications programming and execution from pharma to biopharma and beyond.
  • Prior to joining LHS, Ms. Plumstead was Vice President, Client Navigation at Green Room Communications, a national healthcare public relations agency.
  • Deborah Plumstead said, The growth and recognition of LaVoieHealthScience is a testament to the agencys expertise and its value to clients.

New Federal Guidance Confuses an Already Complicated Landscape for Pharmacists

Retrieved on: 
Thursday, July 14, 2022
Civil and political rights, Confusion, American Pharmacists Association, House, JD, Pharmacy, Multimedia, American, Pharmacist, View, Patient, Descriptive ethics, CEO, Supreme court, Pregnancy, Policy, Office of Inspector General, U.S. Department of Health and Human Services, Doctor of Pharmacy, Trust, House of Delegates, Health, OCR, Dobbs v. Jackson Women's Health Organization, Disability, Supreme, Pharmaceutical industry, Healthcare

The implications of the guidance have the potential to cause widespread unintended consequences beyond reproductive health care services.

Key Points: 
  • The implications of the guidance have the potential to cause widespread unintended consequences beyond reproductive health care services.
  • New federal guidance confuses an already complicated landscape for pharmacists.
  • Bernstein continued, "It only adds more confusion to an already complicated legal and regulatory landscape post-Dobbs that pharmacists must navigate every day to help our patients."
  • "APhA asserts that a pharmacist's independent medication review and use of professional judgment in the medication distribution process is essential to patient safety."

Breaking: FDA permits pharmacists to prescribe Paxlovid to treat COVID-19

Retrieved on: 
Wednesday, July 6, 2022
Federation, FDA, View, Patient, CEO, Pharmacist, CMS, COVID-19, Health equity, Therapy, Doctor of Pharmacy, COVID-19 vaccine, Pharmacy technician, Necessity and sufficiency, JD, American Pharmacists Association, Pharmacy, EUA, Multimedia, American, CDC, Pharmaceutical industry, Healthcare

WASHINGTON, July 6, 2022 /PRNewswire/ -- Today, after months of effort by the American Pharmacists Association (APhA) and other stakeholders, FDA has updated the EUA for the COVID-19 oral antiviral, Paxlovid, to permit pharmacists to order and prescribe Paxlovid under certain conditions.

Key Points: 
  • WASHINGTON, July 6, 2022 /PRNewswire/ -- Today, after months of effort by the American Pharmacists Association (APhA) and other stakeholders, FDA has updated the EUA for the COVID-19 oral antiviral, Paxlovid, to permit pharmacists to order and prescribe Paxlovid under certain conditions.
  • The FDA will permit pharmacists to order and prescribe Paxlovid, the COVID-19 oral antiviral, under certain conditions.
  • The federal government had already authorized pharmacists to order and dispense oral therapeutics under the PREP Act.
  • However, the ability for all pharmacists to prescribe was not included under the conditions in the original EUA for Paxlovid.

APhA Changes Executive Leadership

Retrieved on: 
Friday, June 3, 2022
White House, Federal Government, Public Policy, Government, Healthcare Reform, Health, Public Policy, Pharmaceutical, Leadership, Pharmacist, American Pharmacists Association, Associate, Food, CEO, Washington College of Law, Doctor of Pharmacy, Pfizer, University, American, Senior, Trustee, National, Patient, MS, Compliance, Pharmacy technician, Association, Board, Bachelor of Pharmacy, JD, Regulation of tobacco by the U.S. Food and Drug Administration, Interim, Management, Healthcare, Pharmacy

Bernsteins appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

Key Points: 
  • Bernsteins appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.
  • We have full confidence in Ilisas leadership as Interim CEO during the transition period, said Theresa Tolle, BPharm, FAPhA, APhA President.
  • Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA.
  • Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work and advocate for changes that benefit them, their patients, and their communities.

Global Healthy Living Foundation Study Finds that Empowering Pharmacists to More Widely Immunize Can Increase Vaccine Access, Reduce Health Disparities In Low-Income Communities

Retrieved on: 
Wednesday, May 11, 2022
Health, Infectious Diseases, Hospitals, Other Health, General Health, Pharmaceutical, Policy, Use, United, Progressive Policy Institute, Caregiver, American Pharmacists Association, Quality of life, Native American disease and epidemics, Centers for Medicare & Medicaid Services, Twitter, COVID-19, Journal of the American Pharmacists Association, Patient, Poverty, United States Census, FDA, Center, Osteoporosis, Arthritis, LinkedIn, Awareness, Pioneer Institute, Medicare, National Association, JAMA, Pharming, Medicare Part D, Physician, CDC, Health policy, Association, American Medical Association, CMS, MD, National Council for Prescription Drug Programs, Vaccine, Education, Migraine, Pharmacy, Pharmacist, Cardiovascular disease, Injury, Tourism, National Council, Review, Inflammatory bowel disease, Adult, Immunization, Vaccination, Psoriasis, Social media, Pharmaceutical industry, Health insurance

A peer reviewed paper published in Journal of the American Pharmacists Association from the Global Healthy Living Foundation finds that pharmacists can play a critical role in increasing vaccine access for people who live in low-income communities, particularly seniors, and reduce health disparities.

Key Points: 
  • A peer reviewed paper published in Journal of the American Pharmacists Association from the Global Healthy Living Foundation finds that pharmacists can play a critical role in increasing vaccine access for people who live in low-income communities, particularly seniors, and reduce health disparities.
  • As we return to normalcy, pharmacists are well-positioned to continue providing immunizations at convenient times and locations in all communities across the country.
  • With more than 80,000 retail and outpatient pharmacy locations, pharmacists are the most accessible healthcare professionals in the U.S .
  • Dr. Popovian echoed Dr. Maya, Too many people, especially those in low-income communities and seniors, rely on pharmacists for vaccines.

End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meeting

Retrieved on: 
Tuesday, May 3, 2022
Practice Management, Pharmaceutical, Medical Supplies, General Health, Health, Hospitals, Supply Chain Management, Retail, Board, Communication, Senior, ASHP, CMTM, Assistant professor, American Pharmacists Association, MS, Mayo Clinic, Patient, Doctor of Philosophy, Association, Organization, Program, Pharmacist, Industry, FCCP, MD, Oklahoma Hospital Association, East End Drugs, Alliance, MBA, Vizient, Inc., Solution, CEO, JD, American, Doctor of Pharmacy, Risk, Management, Medicine, Medical device, Pharmacy

"The Alliance has generated a lot of excitement from across the industry for resolving the persistent issue of drug shortages," said Tichy.

Key Points: 
  • "The Alliance has generated a lot of excitement from across the industry for resolving the persistent issue of drug shortages," said Tichy.
  • The End Drug Shortages Alliance was launched in November to address the ongoing crisis and more than 70 organizations have joined to date.
  • Collectively we will end drug shortages through focus on transparency, communication, quality, redundancy and production of additional supply to achieve measurable and sustainable results.
  • The outpouring of support for the End Drug Shortages Alliance throughout the industry has been tremendous, said Mittal Sutaria, Vizient senior vice president, pharmacy contract and program solutions and End Drug Shortages Alliance board member.

APhA House of Delegates Calls for Removal of Barriers to Access to Pharmacist-Provided Patient Care Services

Retrieved on: 
Monday, March 28, 2022
Managed Care, General Health, Professional Services, Pharmaceutical, White House, Federal Government, Healthcare Reform, Public Policy, Insurance, Practice Management, Congressional News, Views, Health, Public Policy, Government, American Pharmacists Association, AMA, Health equity, American Medical Association, Association, House of Delegates, Pharmacist, House, Health, Safety, Indian Medical Association, Pharmacy, Physician, Medicare, Policy, Pharmacy technician, HOD, Patient, Immunization, Healthcare, Delegate

Now is the time for all health care professions to work together to expand access to care during this critical moment for our nation.

Key Points: 
  • Now is the time for all health care professions to work together to expand access to care during this critical moment for our nation.
  • There are no other health care professionals with more extensive training in medication use and safety than pharmacists.
  • Pharmacists provide patient care services related to medications by testing, treating, immunizing, and educating patients; managing medication therapies; and providing consultative advice and information to other health care professionals.
  • APhA adamantly supports the continuation and expansion of collaborative patient care models among pharmacists, physicians, and other health care professionals to improve patient access to care, health equity, and health outcomes.

American Pharmacists Association Applauds Bipartisan Federal Legislation to Combat COVID-19, Improve Patient Equity, and Respond to Future Public Health Threats

Retrieved on: 
Friday, March 25, 2022
FDA, White House, Federal Government, State, Local, Public Policy, Law Enforcement, Emergency Services, Other Policy Issues, Healthcare Reform, Pharmaceutical, Infectious Diseases, Congressional News, Views, Public Policy, Government, Science, Other Science, Health, Research, Member of Congress, American Pharmacists Association, Gaps, CDC, Legislation, Public health, American, Doctor of Pharmacy, CEO, Health, Equitable, Pharmacist, COVID-19 testing, Critical care, MS, Bureau of Labor Statistics, COVID-19, Pharmacy, Medicare, HHS, ECAPS, Patient, Immunization, Healthcare, Pharmaceutical industry, APHA, THE FUTURE OF PHARMACY CARE COALITION

This legislation will ensure patients continue to have access to essential pandemic and pandemic-related care services provided by pharmacists, including services to keep communities safe from COVID-19 and future public health crises.

Key Points: 
  • This legislation will ensure patients continue to have access to essential pandemic and pandemic-related care services provided by pharmacists, including services to keep communities safe from COVID-19 and future public health crises.
  • This legislation will cement pharmacists role in delivering this essential care after the pandemic and in future public health emergencies.
  • This legislation also establishes Medicare coverage and payment for new pharmacy- and pharmacist-provided services in the case of public health emergencies as determined by HHS.
  • This legislation will ensure that millions of patients in communities across the country will continue to receive health care services from pharmacists, alleviating gaps in patient care and advancing health equity.

ASHP Applauds Introduction of Legislation Extending Patient Access to Pharmacists' Pandemic Related Services

Retrieved on: 
Friday, March 25, 2022
Doctor of Science, Human, Pharmacy, Health Mart, American Pharmacists Association, Respiratory syncytial virus, Pharyngealization, Public health, Legislation, American Society of Health-System Pharmacists, CVS Health, Doctor of Pharmacy, National Association, Hospital, Human services, Good Neighbor Pharmacy, Equitable, Cardinal Health, Pharmacist, McKesson Corporation, Society, United States Department of Health and Human Services, COVID-19, RSV, Medicare, Future, Pharmacy technician, Department, Kroger, AmerisourceBergen, ECAPS, Patient, ASHP, Pharmaceutical industry, Healthcare, Health, Walgreens

BETHESDA, Md., March 25, 2022 /PRNewswire/ -- Today, ASHP (American Society of Health-System Pharmacists) applauded the introduction of H.R. 7213, the Equitable Community Access to Pharmacist Services Act (ECAPS), bipartisan legislation that would ensure patients can continue to access essential pandemic and pandemic-related services provided by pharmacists, including services to keep communities safe from COVID-19 and future public health threats. The bill was introduced today by Reps. Ron Kind (D-WI), David B. McKinley (R-WV), Nanette Diaz Barragán (D-CA), and Earl "Buddy" Carter (R-GA).

Key Points: 
  • 7213 , the Equitable Community Access to Pharmacist Services Act (ECAPS), bipartisan legislation that would ensure patients can continue to access essential pandemic and pandemic-related services provided by pharmacists, including services to keep communities safe from COVID-19 and future public health threats.
  • The legislation would also establish Medicare coverage and payment for pharmacist and pharmacy-provided services during public health emergencies designated by the Department of Health and Human Services.
  • "ASHP has been a longstanding leader and advocate for policies that recognize the essential roles pharmacists play as patient care providers.
  • For 80 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety.

Hamilton Beach Brands, Inc. and HealthBeacon plc Announce the US Launch of the Smart Sharps Bin™ Injection Care Management System

Retrieved on: 
Thursday, March 17, 2022
Rheumatoid arthritis, Euronext, Solution, Multiple sclerosis, Hamilton Beach Brands, Facebook, Patient, ID, United Kingdom, Pharmacy, CHI, Partnership, Therapy, FDA, Obesity, Multimedia, FSA, Syringe, Pharmacist, Migraine, Learning, U.S. Postal Service Pro Cycling Team, Restaurant, Asthma, Awareness, Trepp, Artificial intelligence, CEO, Instagram, View, NYSE, Exposition, Efficiency, American Pharmacists Association, Diabetes, Marketing, Pharmaceutical industry, Harbor, Brightline, Amazon, Company

RICHMOND, Va. and DUBLIN, March 17, 2022 /PRNewswire/ -- Hamilton Beach Brands, Inc., a wholly-owned subsidiary of Hamilton Beach Brands Holding Company (NYSE: HBB) and HealthBeacon plc (Euronext: HBCN:ID), a leading developer of smart tools for managing injectable medications at home, announced today the Smart Sharps Bin from Hamilton Beach Health  powered by HealthBeacon is now available in the US from a new direct-to-consumer website, www.smartsharpsbin.com and Amazon.

Key Points: 
  • The "Smart Sharps Bin(TM) from Hamilton Beach Health powered by HealthBeacon" is now available in the US.
  • "Hamilton Beach Brands was very pleased to partner with HealthBeacon in 2021 as the exclusive marketer and distributor of its Injection Care Management System in the US and Canada under a multiyear agreement.
  • The system we are marketing is branded Smart Sharps Bin from Hamilton Beach Health powered by HealthBeacon," saidGreg Trepp, president and CEO, Hamilton Beach Brands, Inc. "For the past several months, our companies have collaborated on the product launch and website development.
  • The Company's consumer brands include Hamilton Beach, Proctor Silex, Hamilton BeachProfessional,Weston, TrueAir, Brightline personal care products, and Hamilton Beach Health.